{"data":{"events":[{"source":"fda_approvals","agency":"FDA","jurisdiction":"US","country":"US","status":"approved","summary":"Labeling","parties":[{"name":"CHEPLAPHARM","role":"current application sponsor","entityId":null,"ticker":null,"exchange":null,"resolution":"unresolved","confidence":0}],"observedAt":"2026-10-04T01:00:00.000Z","language":"en","confidence":1,"externalId":"NDA020766:SUPPL:22","title":"XENICAL: supplement approval","type":"approval","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766","sourceDocumentId":"NDA020766","announcedDate":"2007-01-05","effectiveDate":"2007-01-05","datePrecision":{"announced":"day","effective":"day"},"quote":"{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"22\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20070105\",\n  \"review_priority\": \"STANDARD\",\n  \"submission_class_code\": \"LABELING\",\n  \"submission_class_code_description\": \"Labeling\",\n  \"application_docs\": [\n    {\n      \"id\": \"13381\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020766s022lbl.pdf\",\n      \"date\": \"20070108\",\n      \"type\": \"Label\"\n    },\n    {\n      \"id\": \"25751\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020766s022_ltr.pdf\",\n      \"date\": \"20070112\",\n      \"type\": \"Letter\"\n    }\n  ]\n}","metadata":{"extraction":"deterministic source fields","applicationNumber":"NDA020766","attributionBasis":"Current sponsor of the application; not necessarily the historical sponsor on the approval action date","submissionType":"SUPPL","submissionNumber":"22","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"XENICAL","active_ingredients":[{"name":"ORLISTAT","strength":"120MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}],"reviewPriority":"STANDARD","effectiveDateMeaning":"FDA approval action date"},"deadlineDate":null,"sector":null,"quoteOffset":473,"quoteSourceLength":677,"quoteMatchMode":"whitespace","opinion":null,"sourcePublishedAt":null,"id":"59f68ff9ff738a132e6f1973eef3ba6f","revisionId":"59f68ff9ff738a132e6f1973eef3ba6f:1","revision":1,"changes":[],"supersedesRevisionId":null,"firstSeenAt":"2026-10-04T01:00:00.000Z","lastSeenAt":"2026-10-04T01:00:00.000Z"},{"source":"fda_approvals","agency":"FDA","jurisdiction":"US","country":"US","status":"approved","summary":"Manufacturing (CMC)","parties":[{"name":"CHEPLAPHARM","role":"current application sponsor","entityId":null,"ticker":null,"exchange":null,"resolution":"unresolved","confidence":0}],"observedAt":"2026-10-04T01:00:00.000Z","language":"en","confidence":1,"externalId":"NDA020766:SUPPL:14","title":"XENICAL: supplement approval","type":"approval","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766","sourceDocumentId":"NDA020766","announcedDate":"2002-02-27","effectiveDate":"2002-02-27","datePrecision":{"announced":"day","effective":"day"},"quote":"{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"14\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20020227\",\n  \"review_priority\": \"PRIORITY\",\n  \"submission_class_code\": \"MANUF (CMC)\",\n  \"submission_class_code_description\": \"Manufacturing (CMC)\"\n}","metadata":{"extraction":"deterministic source fields","applicationNumber":"NDA020766","attributionBasis":"Current sponsor of the application; not necessarily the historical sponsor on the approval action date","submissionType":"SUPPL","submissionNumber":"14","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"XENICAL","active_ingredients":[{"name":"ORLISTAT","strength":"120MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}],"reviewPriority":"PRIORITY","effectiveDateMeaning":"FDA approval action date"},"deadlineDate":null,"sector":null,"quoteOffset":473,"quoteSourceLength":283,"quoteMatchMode":"whitespace","opinion":null,"sourcePublishedAt":null,"id":"02044c98983fab923ea948fc388055c1","revisionId":"02044c98983fab923ea948fc388055c1:1","revision":1,"changes":[],"supersedesRevisionId":null,"firstSeenAt":"2026-10-04T01:00:00.000Z","lastSeenAt":"2026-10-04T01:00:00.000Z"},{"source":"fda_approvals","agency":"FDA","jurisdiction":"US","country":"US","status":"approved","summary":"Labeling","parties":[{"name":"CHEPLAPHARM","role":"current application sponsor","entityId":null,"ticker":null,"exchange":null,"resolution":"unresolved","confidence":0}],"observedAt":"2026-10-04T01:00:00.000Z","language":"en","confidence":1,"externalId":"NDA020766:SUPPL:20","title":"XENICAL: supplement approval","type":"approval","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766","sourceDocumentId":"NDA020766","announcedDate":"2004-07-09","effectiveDate":"2004-07-09","datePrecision":{"announced":"day","effective":"day"},"quote":"{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"20\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20040709\",\n  \"review_priority\": \"STANDARD\",\n  \"submission_class_code\": \"LABELING\",\n  \"submission_class_code_description\": \"Labeling\",\n  \"application_docs\": [\n    {\n      \"id\": \"13380\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20766slr020_xenical_lbl.pdf\",\n      \"date\": \"20040714\",\n      \"type\": \"Label\"\n    },\n    {\n      \"id\": \"25749\",\n      \"url\": \"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20766slr020ltr.pdf\",\n      \"date\": \"20040714\",\n      \"type\": \"Letter\"\n    }\n  ]\n}","metadata":{"extraction":"deterministic source fields","applicationNumber":"NDA020766","attributionBasis":"Current sponsor of the application; not necessarily the historical sponsor on the approval action date","submissionType":"SUPPL","submissionNumber":"20","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"XENICAL","active_ingredients":[{"name":"ORLISTAT","strength":"120MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}],"reviewPriority":"STANDARD","effectiveDateMeaning":"FDA approval action date"},"deadlineDate":null,"sector":null,"quoteOffset":473,"quoteSourceLength":687,"quoteMatchMode":"whitespace","opinion":null,"sourcePublishedAt":null,"id":"ab3aa09543d47856ba51f901b8a67aa5","revisionId":"ab3aa09543d47856ba51f901b8a67aa5:1","revision":1,"changes":[],"supersedesRevisionId":null,"firstSeenAt":"2026-10-04T01:00:00.000Z","lastSeenAt":"2026-10-04T01:00:00.000Z"},{"source":"fda_approvals","agency":"FDA","jurisdiction":"US","country":"US","status":"approved","summary":"Manufacturing (CMC)","parties":[{"name":"CHEPLAPHARM","role":"current application sponsor","entityId":null,"ticker":null,"exchange":null,"resolution":"unresolved","confidence":0}],"observedAt":"2026-10-04T01:00:00.000Z","language":"en","confidence":1,"externalId":"NDA020766:SUPPL:12","title":"XENICAL: supplement approval","type":"approval","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766","sourceDocumentId":"NDA020766","announcedDate":"2002-02-21","effectiveDate":"2002-02-21","datePrecision":{"announced":"day","effective":"day"},"quote":"{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"12\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20020221\",\n  \"review_priority\": \"PRIORITY\",\n  \"submission_class_code\": \"MANUF (CMC)\",\n  \"submission_class_code_description\": \"Manufacturing (CMC)\"\n}","metadata":{"extraction":"deterministic source fields","applicationNumber":"NDA020766","attributionBasis":"Current sponsor of the application; not necessarily the historical sponsor on the approval action date","submissionType":"SUPPL","submissionNumber":"12","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"XENICAL","active_ingredients":[{"name":"ORLISTAT","strength":"120MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}],"reviewPriority":"PRIORITY","effectiveDateMeaning":"FDA approval action date"},"deadlineDate":null,"sector":null,"quoteOffset":473,"quoteSourceLength":283,"quoteMatchMode":"whitespace","opinion":null,"sourcePublishedAt":null,"id":"52925edc278dccae12b8f91fe3141d81","revisionId":"52925edc278dccae12b8f91fe3141d81:1","revision":1,"changes":[],"supersedesRevisionId":null,"firstSeenAt":"2026-10-04T01:00:00.000Z","lastSeenAt":"2026-10-04T01:00:00.000Z"},{"source":"fda_approvals","agency":"FDA","jurisdiction":"US","country":"US","status":"approved","summary":"Manufacturing (CMC)","parties":[{"name":"CHEPLAPHARM","role":"current application sponsor","entityId":null,"ticker":null,"exchange":null,"resolution":"unresolved","confidence":0}],"observedAt":"2026-10-04T01:00:00.000Z","language":"en","confidence":1,"externalId":"NDA020766:SUPPL:10","title":"XENICAL: supplement approval","type":"approval","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766","sourceDocumentId":"NDA020766","announcedDate":"2001-12-19","effectiveDate":"2001-12-19","datePrecision":{"announced":"day","effective":"day"},"quote":"{\n  \"submission_type\": \"SUPPL\",\n  \"submission_number\": \"10\",\n  \"submission_status\": \"AP\",\n  \"submission_status_date\": \"20011219\",\n  \"review_priority\": \"PRIORITY\",\n  \"submission_class_code\": \"MANUF (CMC)\",\n  \"submission_class_code_description\": \"Manufacturing (CMC)\"\n}","metadata":{"extraction":"deterministic source fields","applicationNumber":"NDA020766","attributionBasis":"Current sponsor of the application; not necessarily the historical sponsor on the approval action date","submissionType":"SUPPL","submissionNumber":"10","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"XENICAL","active_ingredients":[{"name":"ORLISTAT","strength":"120MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}],"reviewPriority":"PRIORITY","effectiveDateMeaning":"FDA approval action date"},"deadlineDate":null,"sector":null,"quoteOffset":473,"quoteSourceLength":283,"quoteMatchMode":"whitespace","opinion":null,"sourcePublishedAt":null,"id":"4508390e7af8a92cebb1fc1fbb9916c3","revisionId":"4508390e7af8a92cebb1fc1fbb9916c3:1","revision":1,"changes":[],"supersedesRevisionId":null,"firstSeenAt":"2026-10-04T01:00:00.000Z","lastSeenAt":"2026-10-04T01:00:00.000Z"}],"total":5,"limit":100,"offset":0,"asOf":"2026-10-04T01:00:00.000Z","filters":{"limit":100},"coverage":{"totalEvents":8,"linkedEvents":0,"unresolvedParties":0,"jurisdictions":["US"],"firstObservedAt":"2026-10-04T01:00:00.000Z","lastObservedAt":"2026-10-04T01:00:00.000Z","sources":[]},"facets":{"types":[],"agencies":[],"countries":[],"sectors":[],"statuses":[]}},"meta":{"dataset":"catalysts","requestId":"06842e34-45ab-49c8-a1c1-ecc652c0a862","asOf":null,"dataThrough":"2026-10-04T01:00:00.000Z","historyStart":"2026-10-04T01:00:00.000Z","updatedAt":"2026-10-04T01:00:00.000Z","page":null,"next":null,"coverage":{"totalEvents":8,"linkedEvents":0,"jurisdictions":["US"]},"source":[{"id":"government-catalysts","attribution":"Government and regulatory publications","licence":"Use subject to Gloom Datasets terms"}],"notices":[]}}